Balaxi Pharmaceuticals Limited — Captopril Exporter Profile
Indian Pharmaceutical Exporter · #12 for Captopril · $82.1K export value · DGFT Verified
Balaxi Pharmaceuticals Limited is the #12 Indian exporter of Captopril with $82.1K in export value and 13 verified shipments. Balaxi Pharmaceuticals Limited holds a 0.7% market share in Captopril exports across 2 countries. The company exports 2 pharmaceutical products worth $253.2K across 2 therapeutic categories.
Balaxi Pharmaceuticals Limited — Captopril Export Profile: Buyers & Destinations
Where Does Balaxi Pharmaceuticals Limited Export Captopril?
| Country | Value | Shipments | Share |
|---|---|---|---|
| DOMINICAN REPULIC | $52.9K | 9 | 64.4% |
| DOMINICAN REPUBLIC | $25.3K | 2 | 30.8% |
| ANGOLA | $3.9K | 2 | 4.8% |
Balaxi Pharmaceuticals Limited exports Captopril to 3 countries. The largest destination is DOMINICAN REPULIC accounting for 64.4% of Balaxi Pharmaceuticals Limited's Captopril shipments, followed by DOMINICAN REPUBLIC (30.8%) and ANGOLA (4.8%). These destinations reflect Balaxi Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Captopril from Balaxi Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| BALAXI HEALTHCARE DOMINICANA SRL | DOMINICAN REPULIC | $78.2K | 11 |
Balaxi Pharmaceuticals Limited supplies Captopril to 1 buyers globally. The largest buyer is BALAXI HEALTHCARE DOMINICANA SRL (DOMINICAN REPULIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Captopril Export Value and How Much Does Balaxi Pharmaceuticals Limited Contribute?
India exported $4.5M worth of Captopril through 517 shipments from 109 suppliers to 63 countries, serving 170 buyers globally. Balaxi Pharmaceuticals Limited contributes $82.1K to this total, accounting for 0.7% of India's Captopril exports. Balaxi Pharmaceuticals Limited ships Captopril to 3 countries through 1 buyers.
What Is the Average Shipment Value for Balaxi Pharmaceuticals Limited's Captopril Exports?
Balaxi Pharmaceuticals Limited's average Captopril shipment value is $6.3K per consignment, based on 13 shipments totaling $82.1K. The largest destination is DOMINICAN REPULIC (64.4% of Balaxi Pharmaceuticals Limited's Captopril exports).
How Does Balaxi Pharmaceuticals Limited Compare to Other Indian Captopril Exporters?
Balaxi Pharmaceuticals Limited ranks #12 among 109 Indian Captopril exporters with a 0.7% market share. The top 3 exporters are AJANTA PHARMA LIMITED ($1.3M), LINCOLN PHARMACEUTICALS LTD ($1.0M), GRACURE PHARMACEUTICALS LIMITED ($686.2K). Balaxi Pharmaceuticals Limited processed 13 shipments to 2 destination countries.
What Captopril Formulations Does Balaxi Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CAPTOPRIL TABLETS 25 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE NO.BT014/2526) (PACKING-10X10) (10000 TABS/CTN - 10X10X10X10) | $12.7K | 1 |
| CAPTOPRIL TABLETS 25 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE NO.BT017/2526) (PACKING-10X10) (10000 TABS/CTN - 10X10X10X10) | $12.7K | 1 |
| CAPTOPRIL TABLETS 25 MG GSTIN 02AACCB8447R2Z8 TAX INVOICE NO BT028 2526 PACKING 10X10 10000 TABS CTN 10X10X10X10 | $11.8K | 2 |
| CAPTOPRIL TABLETS 25 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE NO.BT251/2324) (PACKING-10X10) (10000 TABS/CTN - 10X10X10X10)TBS | $10.5K | 1 |
| CAPTOPRIL TABLETS 50 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE NO.BT042/2425) (PACKING-10X10) (10000 TABS/CTN - 10X10X10X10) | $10.2K | 1 |
| CAPTOPRIL TABLETS 50 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE NO.BT019/2425) (PACKING-10X10) (10000 TABS/CTN - 10X10X10X10) | $9.7K | 1 |
| CAPTOPRIL 25 MG TABLETS (GSTIN-27AAACG34 | $3.9K | 2 |
| CAPTOPRIL TABLETS 25 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE NO.BT282/2324) (PACKING-10X10) (10000 TABS/CTN - 10X10X10X10) | $3.5K | 1 |
| CAPTOPRIL TABLETS 25 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE NO.BT067/2425) (PACKING-10X10) (10000 TABS/CTN - 10X10X10X10) | $3.5K | 1 |
| CAPTOPRIL TABLETS 25 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE NO.BT042/2425) (PACKING-10X10) (10000 TABS/CTN - 10X10X10X10) | $3.2K | 1 |
Balaxi Pharmaceuticals Limited exports 11 distinct Captopril formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CAPTOPRIL TABLETS 25 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE N with 1 shipments worth $12.7K.
How Does Balaxi Pharmaceuticals Limited Compare to Nearest Captopril Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | AGOG PHARMA LIMITED | $93.5K | 10 | 2 | $9.3K |
| 11 | TORRENT PHARMACEUTICALS LIMITED | $82.9K | 16 | 3 | $5.2K |
| 12 | BALAXI PHARMACEUTICALS LIMITED ★ | $82.1K | 13 | 2 | $6.3K |
| 13 | MICRO LABS LIMITED | $75.6K | 9 | 1 | $8.4K |
| 14 | APPLEX PHARMA | $69.6K | 7 | 1 | $9.9K |
Balaxi Pharmaceuticals Limited ranks #12 among 109 Indian Captopril exporters. Average shipment value of $6.3K compared to the market average of $40.9K. The closest competitors by value are AGOG PHARMA LIMITED and TORRENT PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Captopril Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 96 | 18.6% |
| JNPT/ NHAVA SHEVA SEA | 42 | 8.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 35 | 6.8% |
| JNPT | 28 | 5.4% |
| AHEMDABAD ICD | 26 | 5.0% |
| SAHAR AIR | 25 | 4.8% |
| Jnpt | 18 | 3.5% |
| PATLI ICD | 18 | 3.5% |
About Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited exports 2 products worth $253.2K. Beyond Captopril, top products include Ranitidine. View the complete Balaxi Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Captopril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Captopril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Balaxi Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 13 individual customs records matching Balaxi Pharmaceuticals Limited exporting Captopril, covering 11 formulations to 3 countries via 1 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 63+ countries, 170+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Captopril Export Data from Balaxi Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Balaxi Pharmaceuticals Limited's Captopril exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Balaxi Pharmaceuticals Limited
Full Company Profile →
2 products · $253.2K total trade · 2 categories
Captopril Stats
Company Overview
Top Products by Balaxi Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Balaxi Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Captopril. For current shipment-level data, contact TransData Nexus.